anti-NF2 antibody product blog
Tags: Antibody; Polyclonal Antibody; anti-NF2 antibody; NF2; Neurofibromin 2;
The NF2 n/a (Catalog #MBS719303) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The Rabbit anti-human neurofibromin 2 (merlin) polyclonal Antibody reacts with Human, Mouse, Rat and may cross-react with other species as described in the data sheet. MyBioSource\'s neurofibromin 2 can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB). Researchers should empirically determine the suitability of the NF2 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.The NF2 n/a product has the following accession number(s) (GI #284005154) (NCBI Accession #NP_001164711.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Immunogen: Human NF2. Storage Buffer: PBS with 0.1% Sodium Azide, 50% Glycerol, pH 7.3. -20 degree C, Avoid freeze / thaw cycles.
Santa Cruz Alternative: Potential replacement for Santa Cruz Biotechnology antibody catalog# sc-331 / sc-332 / sc-28247. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing NF2 are readily searchable from our website. Different antibodies against the same target such as NF2 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.